Valuation: Suprema Inc.

Capitalization 305B 209M 177M 162M 153M 285M 18.91B 298M 1.88B 745M 9.11B 783M 767M 32.78B P/E ratio 2025 *
13.6x
P/E ratio 2026 * 9.64x
Enterprise value 229M 157K 133K 122K 115K 214K 14.2M 224K 1.41M 559K 6.83M 588K 576K 24.6M EV / Sales 2025 *
1.92x
EV / Sales 2026 * 1.42x
Free-Float
62%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-4.98%
1 week+0.34%
Current month+0.34%
1 month+11.44%
3 months+29.35%
6 months+32.08%
Current year+12.15%
More quotes
1 week 41,650
Extreme 41650
48,500
1 month 34,500
Extreme 34500
48,800
Current year 34,500
Extreme 34500
48,800
1 year 25,250
Extreme 25250
48,800
3 years 19,020
Extreme 19020
48,800
5 years 19,020
Extreme 19020
48,800
10 years 15,200
Extreme 15200
48,800
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 2021-03-22
Chief Executive Officer 57 2021-03-22
Director of Finance/CFO 58 2020-09-30
Director TitleAgeSince
Chairman 57 2021-03-22
Director/Board Member 56 2021-03-22
Director/Board Member 57 2021-03-22
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-4.98%+0.34%+70.62%+78.98% 209M
+4.37%-2.87%+54.92%+215.73% 5.36B
-1.64%-5.52%+44.53%+631.40% 84.98M
Average -0.75%+0.39%+56.69%+308.70% 1.88B
Weighted average by Cap. +3.93%+3.04%+55.34%+216.93%
See all sector performances

Financials

2025 *2026 *
Net sales 119B 81.47M 68.96M 63.2M 59.86M 111M 7.38B 116M 734M 291M 3.55B 306M 299M 12.79B 142B 97.01M 82.12M 75.27M 71.28M 132M 8.79B 138M 875M 346M 4.23B 364M 356M 15.23B
Net income 22.3B 15.24M 12.9M 11.82M 11.2M 20.79M 1.38B 21.74M 137M 54.4M 665M 57.16M 55.98M 2.39B 32.13B 21.96M 18.59M 17.04M 16.14M 29.96M 1.99B 31.33M 198M 78.39M 958M 82.36M 80.67M 3.45B
Net Debt -76.2B -52.08M -44.08M -40.4M -38.27M -71.06M -4.72B -74.29M -470M -186M -2.27B -195M -191M -8.18B -104B -71.28M -60.34M -55.3M -52.38M -97.26M -6.46B -102M -643M -254M -3.11B -267M -262M -11.19B
More financial data * Estimated data
Logo Suprema Inc.
Suprema Inc. is a Korea-based company engaged in the biometrics business. The Company’s offerings consist of fingerprint systems and fingerprint solutions. Its fingerprint systems include Internet protocol (IP)-based access control and time attendance terminals under the brand names of BioStation, D-Station, FaceStation, BioEntry, BioLite and others. Its fingerprint solutions are used in its related fingerprint systems. The Company distributes its products within domestic market and to overseas markets.
Employees
240
More about the company
Date Price Change Volume
26-02-06 43,850.00 -4.98% 80,147
26-02-05 46,150.00 -0.75% 116,441
26-02-04 46,500.00 +6.65% 140,576
26-02-03 43,600.00 +2.95% 77,007
26-02-02 42,350.00 -3.09% 82,148

End-of-day quote Korea S.E., February 05, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
43,850.00KRW
Average target price
48,500.00KRW
Spread / Average Target
+10.60%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A236200 Stock